COVID-19 National Institute for Health and Care Excellence (NICE)
Best practice, Consultation, Factsheet, Policy, Systematic review
NICE is supporting the NHS and social care to respond quickly to the challenges of the coronavirus pandemic by bringing together information that may help you. Published Guidance and advice list https://www.nice.org.uk/guidance/published?type=cov,coa Rapid evidence summaries will look at whether certain medicines may increase the severity or length of COVID-19 illness ibuprofen and other non-steroidal anti-inflammatory drugs used to reduce temperature and ease flu-like symptoms angiotensin converting enzyme (ACE) inhibitors used to treat high blood pressure or heart failure. NICE are also working with the Medicines and Healthcare products Regulatory Agency. Together to facilitate rapid review of information and advice on the safety and efficacy of treatments for COVID-19.